These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29297008)

  • 1. Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 2005-2015.
    Cheung LC; Katki HA; Chaturvedi AK; Jemal A; Berg CD
    Ann Intern Med; 2018 Feb; 168(3):229-232. PubMed ID: 29297008
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States.
    Landy R; Cheung LC; Berg CD; Chaturvedi AK; Robbins HA; Katki HA
    Ann Intern Med; 2019 Sep; 171(5):384-386. PubMed ID: 31158854
    [No Abstract]   [Full Text] [Related]  

  • 3. The United States Preventive Services Task Force recommendations for lung cancer screening.
    Blackmon SH; Feinglass SR
    Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking.
    Li CC; Matthews AK; Rywant MM; Hallgren E; Shah RC
    Cancer Causes Control; 2019 Mar; 30(3):235-240. PubMed ID: 30377905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
    Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
    Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
    [No Abstract]   [Full Text] [Related]  

  • 6. Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening.
    Cheung LC; Berg CD; Castle PE; Katki HA; Chaturvedi AK
    Ann Intern Med; 2019 Nov; 171(9):623-632. PubMed ID: 31634914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Task force recommends targeted lung cancer screening.
    Friedrich MJ
    JAMA; 2013 Sep; 310(9):892-3. PubMed ID: 24002258
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. Screening for lung cancer: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Mar; 160(5):I-40. PubMed ID: 24378963
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for Lung Cancer With Low-Dose Computed Tomography: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center.
    Smetana GW; Boiselle PM; Schwartzstein RM
    Ann Intern Med; 2015 Apr; 162(8):577-82. PubMed ID: 25894026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard?
    Carter-Harris L; Gould MK
    Ann Am Thorac Soc; 2017 Aug; 14(8):1261-1265. PubMed ID: 28541749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.S. Preventive Services Task Force Final Recommendation Statement, Evidence Summary, and Modeling Studies on Screening for Lung Cancer.
    Mitchell EP
    J Natl Med Assoc; 2021 Jun; 113(3):239-240. PubMed ID: 34274036
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
    Hüsing A; Kaaks R
    Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating efficacy of current lung cancer screening guidelines.
    Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
    J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Lung Cancer: Effective Recruitment Methods.
    Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):514-517. PubMed ID: 29261350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer screening trials: the United States and beyond.
    Jacobson FL; Jaklitsch MT
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S3-6. PubMed ID: 22676977
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening with low-dose computed tomography: an analysis of the MEDCAC decision.
    Parker MS; Groves RC; Fowler AA; Shepherd RW; Cassano AD; Cafaro PL; Chestnut GT
    J Thorac Imaging; 2015 Jan; 30(1):15-23. PubMed ID: 25286290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.